SREBP2 is upregulated in esophageal squamous cell carcinoma and co-operates with c-Myc to regulate HMGCR expression

Dysregulations of the mevalonate pathway (MVA) have been previously identified. Our previous study demonstrated that 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the rate-limiting enzyme of the MVA pathway, was upregulated in esophageal squamous cell carcinoma (ESCC) and statin-inhibited...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Chenxi, Fan, Limin, Li, Zhigang, Yao, Feng, Zhao, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755167/
https://www.ncbi.nlm.nih.gov/pubmed/31432128
http://dx.doi.org/10.3892/mmr.2019.10577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755167/
https://www.ncbi.nlm.nih.gov/pubmed/31432128
http://dx.doi.org/10.3892/mmr.2019.10577

Ejemplares similares